First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This trial will look at 2 different drug combinations that have well known safety profiles
and are known to be active against non small cell lung cancer and combine them with
bevacizumab, an experimental drug that has shown effectiveness when added to other drug
combinations for advanced non-small cell lung cancer. The primary objective in this study is
to see how well this combination of drugs keeps the cancer from getting worse in this elderly
population of non-small cell lung cancer patients.